文献速递神经肿瘤神经重症

老年恶性脑肿瘤患者临终关怀、抗癌治疗与Medicare支出

Hospice care, cancer-directed therapy, and Medicare expenditures among older patients dying with malignant brain tumors.
PubMed 文献 · Neuro Oncol · 2018-01-01

这项回顾性队列研究纳入2012-2015年东南部癌症社区网络中去世的≥65岁Medicare受益者,包括原发性恶性脑肿瘤(PMBT)383例和继发性MBT(SMBT)940例。24%的PMBT患者和32%的SMBT患者接受晚期(死亡前1-3天)或无临终关怀;SMBT患者接受晚期临终关怀的比例高于PMBT患者(10% vs 5%,P=0.002)。接受临终关怀与PMBT患者Medicare支出平均减少12138美元(95%CI:-18065至-6210)相关。

要点

  • 24%的PMBT患者和32%的SMBT患者接受晚期(死亡前1-3天)或无临终关怀。
  • SMBT患者接受晚期临终关怀的比例高于PMBT患者(10% vs 5%,P=0.002)。
  • 接受临终关怀与PMBT患者Medicare支出平均减少12138美元相关(95%CI:-18065至-6210)。

核心结论

  • 在老年恶性脑肿瘤患者中,接受晚期或无临终关怀较为常见,且与PMBT患者Medicare总支出增加显著相关。

研究设计与样本

  • 回顾性队列研究,纳入2012-2015年在东南部癌症社区网络(包括学术和社区医院)接受治疗的去世的≥65岁Medicare受益者,包括PMBT患者383例和SMBT患者940例。

主要发现

  • 24%的PMBT患者(n=383)和32%的SMBT患者(n=940)接受晚期(死亡前1-3天)或无临终关怀。
  • SMBT患者接受晚期临终关怀的比例高于PMBT患者(10% vs 5%,P=0.002)。
  • 接受抗癌治疗的患者比例:PMBT为18%,SMBT为25%(P=0.003)。
  • 非白人种族、男性以及在生命最后30天内接受任何医院治疗与晚期或无临终关怀风险增加相关。
  • 接受临终关怀与Medicare支出平均减少相关:PMBT患者为-12138美元(95%CI:-18065至-6210),SMBT患者为-1508美元(95%CI:-3613至598)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: End-of-life care for older adults with malignant brain tumors is poorly understood. The purpose of this study is to quantify end-of-life utilization of hospice care, cancer-directed therapy, and associated Medicare expenditures among older adults with malignant brain tumors. METHODS: This retrospective cohort study included deceased Medicare beneficiaries age ≥65 with primary malignant brain tumor (PMBT) or secondary MBT (SMBT) receiving care within a southeastern cancer community network including academic and community hospitals from 2012-2015. Utilization of hospice and cancer-directed therapy and total Medicare expenditures in the last 30 days of life were calculated using generalized linear and mixed effect models, respectively. RESULTS: Late (1-3 days prior to death) or no hospice care was received by 24% of PMBT (n = 383) and 32% of SMBT (n = 940) patients. SMBT patients received late hospice care more frequently than PMBT patients (10% vs 5%, P = 0.002). Cancer-directed therapy was administered to 18% of patients with PMBT versus 25% with SMBT (P = 0.003). Nonwhite race, male sex, and receipt of any hospital-based care in the final 30 days of life were associated with increased risk of late or no hospice care. The average decrease in Medicare expenditures associated with hospice utilization for patients with PMBT was $-12,138 (95% CI: $-18,065 to $-6210) and with SMBT was $-1,508 (95% CI: $-3,613 to $598). CONCLUSIONS: Receiving late or no hospice care was common among older patients with malignant brain tumors and was significantly associated with increased total Medicare expenditures for patients with PMBT.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Dover LL, Dulaney CR, Williams CP, et al. Hospice care, cancer-directed therapy, and Medicare expenditures among older patients dying with malignant brain tumors. Neuro Oncol. 2018. PMID: 29156054. doi:10.1093/neuonc/nox220

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。